Pinnacle Wealth Planning Services’s Corcept Therapeutics CORT Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$337K	Buy	3,880 +136	+4%	+$8.21K	0.03%	333
2026 Q1	$151K	Buy	3,744 +278	+8%	+$10.4K	0.02%	584
2025 Q4	$121K	Sell	3,466 -146	-4%	-$11.5K	0.01%	683
2025 Q3	$300K	Sell	3,612 -19	-0.5%	-$1.38K	0.04%	315
2025 Q2	$267K	Buy	+3,631	New	+$263K	0.04%	332
2021 Q1	–	Sell	-330	Closed	-$9K	–	694
2020 Q4	$9K	Buy	+330	New	+$6.95K	﹤0.01%	1418

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Wealth Planning Services's CORT Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its Corcept Therapeutics (CORT) stake by 3.6% in Q2 2026, buying an estimated $8.21K and bringing the position to 3,880 shares worth $337K. The position accounts for 0.03% of the portfolio, ranked #333.

Pinnacle Wealth Planning Services first reported a position in CORT in Q4 2020 and has held it in 6 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Pinnacle Wealth Planning Services held 3,880 shares of Corcept Therapeutics worth $337K as of Q2 2026.
Pinnacle Wealth Planning Services bought 136 Corcept Therapeutics shares in Q2 2026, an estimated $8.21K.
Corcept Therapeutics made up 0.03% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #333 holding.
Pinnacle Wealth Planning Services first reported a position in Corcept Therapeutics in Q4 2020 and has held it in 6 quarters since.
423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.